12 West Capital Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,249,646
| Closed | -$56.5M | – | 23 |
|
|
2022
Q2 | $56.5M | Sell |
1,249,646
-1,268,854
| -50% | -$57.4M | 4.82% | 8 |
|
|
2022
Q1 | $192M | Buy |
2,518,500
+514,500
| +26% | +$39.1M | 11.65% | 2 |
|
|
2021
Q4 | $299M | Buy |
2,004,000
+82,000
| +4% | +$12.2M | 13.24% | 3 |
|
|
2021
Q3 | $280M | Hold |
1,922,000
| – | – | 12.76% | 4 |
|
|
2021
Q2 | $376M | Hold |
1,922,000
| – | – | 15.78% | 2 |
|
|
2021
Q1 | $348M | Hold |
1,922,000
| – | – | 16.58% | 2 |
|
|
2020
Q4 | $272M | Hold |
1,922,000
| – | – | 11.69% | 2 |
|
|
2020
Q3 | $240M | Buy |
1,922,000
+487,000
| +34% | +$60.7M | 11.66% | 2 |
|
|
2020
Q2 | $128M | Buy |
+1,435,000
| New | +$128M | 6.62% | 5 |
|